(DKS) Dick’s Sporting Goods - Overview
Stock: Sporting Goods, Apparel, Footwear, Fitness Equipment
| Risk 5d forecast | |
|---|---|
| Volatility | 38.3% |
| Relative Tail Risk | -10.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.05 |
| Alpha | -27.36 |
| Character TTM | |
|---|---|
| Beta | 1.266 |
| Beta Downside | 1.432 |
| Drawdowns 3y | |
|---|---|
| Max DD | 32.73% |
| CAGR/Max DD | 0.43 |
EPS (Earnings per Share)
Revenue
Description: DKS Dick’s Sporting Goods March 03, 2026
Dick’s Sporting Goods (NYSE: DKS) is a U.S.-based omni-channel retailer that sells a broad range of sporting-goods hardlines, apparel, footwear and accessories through its flagship stores, specialty concepts (e.g., Golf Galaxy, Moosejaw, Going Going Gone!), and digital channels, including a youth-sports mobile app called GameChanger.
For the fiscal year ended January 2025, DKS reported revenue of $3.62 billion, a 4.8% increase YoY, driven by a 5.3% rise in comparable-store sales and a 31% contribution from e-commerce, which now accounts for roughly one-third of total sales. The company posted an adjusted operating margin of 5.2% and earnings per share of $2.15, while inventory turnover improved to 4.9×, reflecting tighter supply-chain management.
Key macro and sector drivers include resilient consumer discretionary spending despite modest inflationary pressure, a 2.1% annual growth in U.S. sports participation rates, and continued demand for athleisure and outdoor recreation gear-segments where DKS’s specialty stores and private-label offerings have outperformed the broader specialty retail index, which has lagged at a 1.8% revenue CAGR over the past three years.
For a deeper dive into DKS’s valuation dynamics, you might explore the analytics available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 1.02b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -5.89 > 1.0 |
| NWC/Revenue: 17.97% < 20% (prev 17.27%; Δ 0.70% < -1%) |
| CFO/TA 0.07 > 3% & CFO 1.17b > Net Income 1.02b |
| Net Debt (6.88b) to EBITDA (1.73b): 3.97 < 3 |
| Current Ratio: 1.57 > 1.5 & < 3 |
| Outstanding Shares: last quarter (87.1m) vs 12m ago 5.24% < -2% |
| Gross Margin: 35.33% > 18% (prev 0.36%; Δ 3498 % > 0.5%) |
| Asset Turnover: 106.8% > 50% (prev 128.5%; Δ -21.68% > 0%) |
| Interest Coverage Ratio: 21.86 > 6 (EBITDA TTM 1.73b / Interest Expense TTM 59.3m) |
Altman Z'' 3.51
| A: 0.15 (Total Current Assets 7.35b - Total Current Liabilities 4.68b) / Total Assets 17.43b |
| B: 0.39 (Retained Earnings 6.81b / Total Assets 17.43b) |
| C: 0.09 (EBIT TTM 1.30b / Avg Total Assets 13.94b) |
| D: 0.57 (Book Value of Equity 6.80b / Total Liabilities 11.91b) |
| Altman-Z'' Score: 3.51 = A |
Beneish M -1.51
| DSRI: 1.90 (Receivables 474.8m/225.7m, Revenue 14.88b/13.43b) |
| GMI: 1.01 (GM 35.33% / 35.74%) |
| AQI: 2.17 (AQ_t 0.12 / AQ_t-1 0.06) |
| SGI: 1.11 (Revenue 14.88b / 13.43b) |
| TATA: -0.01 (NI 1.02b - CFO 1.17b) / TA 17.43b) |
| Beneish M-Score: -1.51 (Cap -4..+1) = CCC |
What is the price of DKS shares?
Over the past week, the price has changed by -5.19%, over one month by -0.77%, over three months by -11.12% and over the past year by -3.85%.
Is DKS a buy, sell or hold?
- StrongBuy: 8
- Buy: 2
- Hold: 15
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the DKS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 238.3 | 18.3% |
| Analysts Target Price | 238.3 | 18.3% |
DKS Fundamental Data Overview March 03, 2026
P/E Forward = 13.7174
P/S = 1.231
P/B = 3.3187
P/EG = 1.996
Revenue TTM = 14.88b USD
EBIT TTM = 1.30b USD
EBITDA TTM = 1.73b USD
Long Term Debt = 1.90b USD (from longTermDebt, last quarter)
Short Term Debt = 995.5m USD (from shortTermDebt, last quarter)
Debt = 7.70b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.88b USD (from netDebt column, last quarter)
Enterprise Value = 25.20b USD (18.32b + Debt 7.70b - CCE 821.3m)
Interest Coverage Ratio = 21.86 (Ebit TTM 1.30b / Interest Expense TTM 59.3m)
EV/FCF = 179.5x (Enterprise Value 25.20b / FCF TTM 140.4m)
FCF Yield = 0.56% (FCF TTM 140.4m / Enterprise Value 25.20b)
FCF Margin = 0.94% (FCF TTM 140.4m / Revenue TTM 14.88b)
Net Margin = 6.86% (Net Income TTM 1.02b / Revenue TTM 14.88b)
Gross Margin = 35.33% ((Revenue TTM 14.88b - Cost of Revenue TTM 9.62b) / Revenue TTM)
Gross Margin QoQ = 33.13% (prev 37.06%)
Tobins Q-Ratio = 1.45 (Enterprise Value 25.20b / Total Assets 17.43b)
Interest Expense / Debt = 0.24% (Interest Expense 18.3m / Debt 7.70b)
Taxrate = 27.96% (29.2m / 104.4m)
NOPAT = 933.4m (EBIT 1.30b * (1 - 27.96%))
Current Ratio = 1.57 (Total Current Assets 7.35b / Total Current Liabilities 4.68b)
Debt / Equity = 1.39 (Debt 7.70b / totalStockholderEquity, last quarter 5.52b)
Debt / EBITDA = 3.97 (Net Debt 6.88b / EBITDA 1.73b)
Debt / FCF = 48.99 (Net Debt 6.88b / FCF TTM 140.4m)
Total Stockholder Equity = 3.78b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.32% (Net Income 1.02b / Total Assets 17.43b)
RoE = 27.00% (Net Income TTM 1.02b / Total Stockholder Equity 3.78b)
RoCE = 22.79% (EBIT 1.30b / Capital Employed (Equity 3.78b + L.T.Debt 1.90b))
RoIC = 17.38% (NOPAT 933.4m / Invested Capital 5.37b)
WACC = 7.50% (E(18.32b)/V(26.02b) * Re(10.58%) + D(7.70b)/V(26.02b) * Rd(0.24%) * (1-Tc(0.28)))
Discount Rate = 10.58% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.66%
[DCF] Terminal Value 74.25% ; FCFF base≈364.0m ; Y1≈258.8m ; Y5≈138.6m
[DCF] Fair Price = N/A (negative equity: EV 2.91b - Net Debt 6.88b = -3.97b; debt exceeds intrinsic value)
EPS Correlation: -35.33 | EPS CAGR: -46.10% | SUE: -4.0 | # QB: 0
Revenue Correlation: 55.42 | Revenue CAGR: 5.98% | SUE: -4.0 | # QB: 0
EPS next Quarter (2026-04-30): EPS=3.03 | Chg7d=+0.003 | Chg30d=+0.003 | Revisions Net=+1 | Analysts=16
EPS next Year (2027-01-31): EPS=14.83 | Chg7d=+0.006 | Chg30d=+0.006 | Revisions Net=+1 | Growth EPS=+16.2% | Growth Revenue=+28.6%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.5% (Discount Rate 10.6% - Earnings Yield 6.0%)
[Growth] Growth Spread = +54.2% (Analyst 58.7% - Implied 4.5%)